Company / Interest Expense per Share
BeOne Medicines Ltd. Interest Expense per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.04
FY2025
5-year range
$0.02 / $0.04
FY2021-FY2025
Trend
+4.4%
vs FY2024
Sector context
#34 of 43
Health Care
What the data says
BeOne Medicines Ltd.'s interest expense per share of $0.04 is lower than 79% of companies in the Health Care sector (FY2025). Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.02 in FY2023 to $0.04 in FY2025.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of +9.5%.
Increased from $0.02 to $0.04 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +30.3%
- 5-Year CAGR
- +9.5%
- 10-Year CAGR
- -
Sector benchmark
-99.6% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share increased 4.4% year-over-year.
- Ranks #34 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +4.4% |
| FY2024 | $0.03 | +124.9% |
| FY2023 | $0.02 | -5.7% |
| FY2022 | $0.02 | -33.0% |
| FY2021 | $0.02 | +6.2% |
| FY2020 | $0.02 | +17.0% |
| FY2019 | $0.02 | -12.1% |
| FY2018 | $0.02 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026